In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Encompass Health (EHC – Research Report), with a ...

After a dismal 2024, CVS Health (NYSE:CVS) could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain on Wednesday posted a big beat on ...

Truist Financial analyst David S Macdonald maintained a Hold rating on DaVita (DVA – Research Report) today. The company’s shares closed ...

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...

Right now there is still time for a deal to be reached, but the negotiations between Cigna and Bon Secours have been ongoing ...

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects ...

During the last three months, 11 analysts shared their evaluations of CVS Health CVS +0.18% Get Free Report , revealing ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

On the revenue side, PBMs get paid by insurance companies to secure rebates from drugmakers in exchange for favorable ...

The Morning Briefing will not be published Monday, Feb. 17, in celebration of Presidents Day. Look for it again in your inbox Tuesday. RFK Jr. Is Sworn In To Lead HHS Amid A Backdrop Of Budget, Staff ...